chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt. reported over the phone that around 5 hours after receiving the 1st dose of pfizer she had swelling of face and hands w/ some mild breathing distress where she had to "breath from the bottom of the stomach". She called to inquire about taking pain medication for back pain she was having and then brought up her reactions to the vaccination. She later wanted me to not make a note in her profile or report to VAERS as she is now concerned about not being able to get the 2nd dose and she now wants to get moderna instead. I said she would likely have to get either the 2nd pfizer or a moderna at the hospital where they are better equipped to deal with potential severe reactions and her primary care provider can advise her based on her entire medical profile/history. 9/29/21 14:37
Received TD and Pneumococcal on 12/28/00 at 15:00 and by evening had pain in left arm, shoulder, soreness in left arm pit, nausea, fever and headache. On 12/29/00, arm still with soreness, sore to touch and move (not as bad as yesterday). Still with headache.
come in well for vaccines, received DTaP, IPV, MMR. 3 hours later developed hight (tactile) temp and vomiting. Recurrent tactile fever ( up and down with Tylenol) and continuous vomiting x 24 hr, then resolved completely. No diarrhea, no ST, no URI, Sx. rapid strep negative.
Had a temperature of about 103, shaking, very achey and hard to walk and my arm hurt where I received the shot.  Took one dose of Vicks cold/flu tablets (2) and took Tylenol (1 - 650 mg.) the next day.  Recovered in about a day and a half.
Severe headache beginning around 5:00 PM and lasting through the night.  It was mild the next day, but the third day the headach returned.  I have not taken anything for the headache since it was advised not to take Tylenol or Advil after the shot.
itch; cold sore; Rash on my lower back; red and minorly sore throat; red and minorly sore throat; This is a spontaneous report from a contactable consumer or other non hcp.  A 70-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EL9267 and expiration date was not reported), via an unspecified route of administration on 24Feb2021 (at the age of 70 years) as 1st dose, single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not diagnosed with COVID-19, prior vaccination and since the vaccination. On 08Mar2021(two weeks after first injection) the patient experienced cold sore that was dormant over 20 years, rash on lower back, red and minorly sore throat, red and minorly sore throat, itch. Adverse events resulted in clinic visit. Reporter assessed the event as non-serious. Patient was treated with Steroid for itch and antiviral for cold sore. The outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
7 days post injection noticed a severe itching sensation at injection site. Area was very warm to the touch. Bright red raised oval patch measuring 2.5? wide & 2.25? tall. Treated with ice packs frequently for 3 days & topical diphenhydramine 2% cream to-wide for 4-5 days.  4th day the center started exhibiting a pale color & itching has started to subside. 5th day slight redness remaining around the outside border, itching is rare.
12 hours after receiving the shot I came down with chills, fever, and body aches. I had three bouts of this over the next 24 hours. The second one had a spike in fever just over 101. I monitored my symptoms closely and used Tylenol as recommended.
A FAMILY MEMBER OF PATIENT WITH RX# 7006047-1041, CAME OVER STATING THAT WE GAVE PATIENT A 3RD MODERNA SHOT. SHE STATED THE VACCINE CARD ALREADY REFLECTED 2 SHOTS WHICH SHE VERIFIED WITH DOCTOR (THERE WAS ONLY ONE LOT NUMBER) AND WE GAVE HIM A THIRD ONE. PATIENT CAME IN ON 7/1/2021 AS A WALK IN AND REQUESTED HIS SECOND SHOT. PATIENT FILLED CONSENT FORM AND SHOT WAS BILLED AS 2ND SHOT VIA MEDICAID, FL SHOTS WAS VERIFIED AND ONLY SHOWED ONE SHOT, AND WE ASKED PATIENT "IS THIS YOUR FIRST SHOT OR SECOND SHOT?" AS IS OUR STANDARD PROCESS. Family member claims pt had dizziness and fainting resulting in hospitalization.
Infant developed temp >102.5, became lethargic and very poorly responsive. Required EMS assistance (911). Evaluated at local hospital, had blood and urine collected. Seen in my office next day - normal exam.
Everything hurt; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Everything hurt) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     Concurrent medical conditions included Fibromyalgia (so she usually has aches and pains). Concomitant products included HYDROCODONE, LORAZEPAM, VITIS VINIFERA SEED (GRAPE SEED EXTRACT HS), IODINE, VITAMINS NOS, MAGNESIUM and PROBIOTICS NOS for an unknown indication.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced MYALGIA (Everything hurt). At the time of the report, MYALGIA (Everything hurt) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other concomitant medication included  something for macular degeneration.  No treatment information was provided by the reporter.    This case was linked to MOD-2021-280740 (Patient Link).
Entire left arm became swollen, warm and tender. Arm was at least 50% bigger than right arm. He had so much swelling that he could not lift his arm due to pain and swelling. Developed a low grade temp but did not develop a fever.
diarrhea; patient has lost 18 pounds in 4 days; This is a spontaneous report from a contactable consumer. A 87-years-old male patient received bnt162b2 (BNT162B2, solution for injection, Lot number and expiry date was not reported) dose 1 via an unspecified route of administration at arm right on 20Feb2021 (at a age of 87-years-old) as a single dose for covid-19 immunisation. Medical history included renal failure from an unknown date and unknown if ongoing. The reporter stated that her fiance was on dialysis, and had a history of kidney failure, fistula from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. Reporter stated that she was called for her fiance who had the COVID vaccine last week, on saturday, 20Feb2021 and her fiance has been having diarrhoea since sunday night up until today (reporting day), so for 4 days, give or take a few hours. Reporter stated that her fiance's diarrhoea had never been solid, it was just liquid. Reporter stated that the patient's doctor is out of town and the reporter can't determine if this was mild, moderate, or severe. Reporter was wondering if this could be a side effect from the vaccine, and she was wondering if the patient should get the second dose. The reporter stated on feb2021 that the patient had lost 18 pounds in 4 days and he was now down to 180 pounds. The patient underwent lab tests and procedures which included weight lost 18 pounds on Feb2021 patient had lost 18 pounds in 4 days and he was now down to 180 pounds. Outcome of the event diarrhoea was resolved on 25Feb2021 while outcome of weight lost was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
I have different a number of recurrent episodes of mollaret's meningitis from hsv2 infection since 2007 however it's been about 4 years since the last episode prior to receiving the 2nd dose of the moderna vaccine. I received the 2nd dose on the night of April 2nd and had typical low grade fever, aches, and chills which started on April third and subsided by April 4th. The morning of April 6th, I began to notice the usual symptoms of a mollaret's meningitis episode and by the night of the 6th it was the worst episode I have had since the original in 2007 when I was hospitalized for it. For reference, the episodes had been getting less frequent and less severe as time went on.
It was reported in a published article that a female patient (age not reported) was vaccinated on an unspecified date with a dose of MMR (second generation) (lot # not reported). Three weeks after she received the vaccine she developed Kawasaki disease. She was treated vigorously, and received IVIG, but went on to develop a left descending coronary artery aneurysm. The patient was described as having slow motor skills and it was reported that she was in an early intervention program. The author stated that in spite of its limitation, this study suggests that an autism/vaccine connection may exist. Upon internal review, Kawasaki disease, coronary artery aneurysm and slow motor skills were determined to be other important medical event (OMIC). No further information is available.
This spontaneous report was received from a medical assistant referring to a 18 year old patient of an unspecified gender. The patient's medical history, concurrent conditions and concomitant therapy were not provided. On 25-JUL-2018, the patient was vaccinated with an adult dose of VAQTA (dose, frequency and route were unknown) lot # N028743 for prophylaxis. No adverse effects reported.
Arm turned bright rosy pink/red in a 2?  area, then extreme pain, throbbing, heat, fever,  and then area extended down and around arm.  At this time it was lighter: spreading out. Began to itch.  Still hurting somewhat at varied times but not  nearly as bad.
On 9-17-2009 patient called me to report injection site causing discomfort and pain in her (L) shoulder. Stated, "I feel the injection was given too high." Client is using a heating pad and taking pain medication with no improvement. Small bruise at site per client. Client to come to clinic this afternoon for site inspection. Client in clinic at 4:15 p.m. and site inspected by myself and another RN. Small bruise located in (L) far upper arm, slightly posterior. Bruise not located on deltoid muscle. Site not red, warm to touch or excessively swollen at this time, but is painful to touch with only a small amount of swelling. No knot at injection site. Pictures taken with client's signed consent. Client states that site is so painful that she is staying awake at night. Wants pain to stop. Client referred to urgent care for evaluation. District notified and urgent care called to report referral/problem. If injection site is the area where small bruise is located, injection was given too high. Checking to see if injection needs to be repeated (question absorption at current site). 9-18-2009 phone call to client at 7:45 a.m. to determine if any treatment was recommended and to determine if client was feeling better. No answer, client was to call me today when she had her planning period.
Patient came in for a primary dose, she received a vaccine from the grey border box of moderna bivalent; no adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (Patient came in for a primary dose, she received a vaccine from the grey border box of moderna bivalent) and NO ADVERSE EVENT (no adverse event) in a female patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 011H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (Patient came in for a primary dose, she received a vaccine from the grey border box of moderna bivalent) and NO ADVERSE EVENT (no adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Patient came in for a primary dose, she received a vaccine from the grey border box of moderna bivalent) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Patient came in for a primary dose, she received a vaccine from the grey border box of moderna bivalent).    Concomitant medication details not reported by the reporter. Patient came in for a primary dose, she received a vaccine from the grey border box of moderna bivalent. It was the pharmacist understanding that the vaccine could be used as primary or booster. On the website when filing it says invalid and it is only a booster. Treatment details was not reported by the reporter.
Right sided facial & top lip Numbness & recurring pain; Right sided facial & top lip Numbness & recurring pain; Right sided facial & top lip Numbness & recurring pain; This is a spontaneous report from a contactable consumer reporting for herself. A 66-year-old female patient (not pregnant at the time of vaccination) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number EK9231), via unspecified route of administration on 29Dec2020 13:30 on left arm at single dose for COVID-19 immunization. Facility where the most recent COVID-19 vaccine was administered in Hospital. Medical history included Hypertension, Reflux and low back pain. Concomitant medications included ibuprofen, dicycloverine hydrochloride (BENTYL), Valsartan and omeprazole. The patient previously took codeine, Bactrim, Zyrtec and experienced allergies. The patient experienced Right sided facial and top lip Numbness, recurring pain on 31Dec2020 16:00. All events resulted in emergency room visit and Hospitalization on 31Dec2020 for 1 day. The patient underwent lab tests and procedures, which included Cat scan, MRI, ultrasound of heart and labs on unspecified dates, Nasal Swab/Covid 19 test on 01Jan2021 with negative result. The outcome of the events were not resolved.
My grandson came over to visit on my birthday, he was not feeling well. I started not feeling well, I had a massive headache, a cough, runny nose. body ache, my taste became very intense, extremely tired, sleepiness. I used a home COVID-19 test, that came back positive. I called my doctor, had a virtual visit, discussed my symptoms. I was prescribed, Paxlovid that I started taking immediately. I have recovered I am just very fatigued and congestioned.
Patient stated she felt light headed, hot and nauseous just minutes after the vaccine. This only lasted a few minutes and the patient relaxed and drank water and felt better.
84 y/o M PMHx of non-hodgkin's lymphoma, adenocarcinoma of the colon (1996) and type 2 DM, presented ED 4/17 with complaints of weakness x 1 week. He reported some Memory loss but denied fever/chills, coughing, dyspnea or fever. Admitted for UTI. On 4/19 patient developed fever, tested positive COVID, started on decadron and remdesivir, pulmonology consulted. 5/1 increasing O2 requirements, prompting transfer to ICU. Mental status improved. 5/3: Fluctuant FiO2 requirements. Transferred to the floor and back to the ICU for hypoxemia. Intubated 5/7. Pt with worsening AKI, metabolic acidosis and shock in the evening of 5/8. Daughter on 5/9 and pt made a DNR. Worsening shock, metabolic acidosis and MODS. Decision to dc to hospice
Pt started screaming about 2PM & cried constantly until 630PM; highest temp 101 ax; seen by MD 21AUG91-felt is allergic to pertussis;
The morning of 3/29/2021 patient noticed right side facial drooping/paralysis around 8:30am. Her vaccine dose of COVID-19 (Janssen) was given on 3/8/2021. Patient was seen by her general practitioner on 3/29/2021. He ordered a brain CT with contrast. Patient is awaiting results. She was given prednisone 10mg  twice daily. She is going to follow up with physician today (3/31/2021).
discoloration all over her body / shape is strawberry and color is white; This spontaneous case was reported by a consumer and describes the occurrence of SKIN DISCOLOURATION (discoloration all over her body / shape is strawberry and color is white) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Infection since 12-Jan-2021. Concomitant products included LEVOFLOXACIN (LEVAQUIN) from 12-Jan-2021 to an unknown date for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jan-2021, the patient experienced SKIN DISCOLOURATION (discoloration all over her body / shape is strawberry and color is white). At the time of the report, SKIN DISCOLOURATION (discoloration all over her body / shape is strawberry and color is white) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No treatment information provided.
Within 1-2 minutes after receiving vaccines, I was notified by the medical assistant that patient was breaking out in a rash. I observed diffuse red splotchy lesions mostly flat with few raised areas. Areas of well demarcated erythema as well as faded borders noted. Largely covering thighs, arms, cheeks, forehead, and onto scalp. Pt was not scratching at skin. Lungs CTA, breathing comfortably. Administered Benadryl 2.5 mL at 9:55am and rash was near resolved by 10:15am.
Vaccine administered was stored great than thirty days in refrigerated temperatures. A case opened with the vaccine manufacturer demonstrated that the vaccines were still safe and effective but requested that we report to VAERS.
Heavy menstrual bleeding for the second time in a menstrual cycle.  Very uncommon for me personally.   Initial mensuration cycle began on Tuesday August 22 and ended on August 29 which consisted of a much heavier and brighter flow, and the current mensuration began  Thursday, September 10.  This is a very heavy and dark flow.   Both times are inconsistent with my "normal" cycles in which are about 5 days long with maybe one heavy day of bleeding.
Red, inflamed, did not feel well, weakness in legs, nausea, possibly heart racing.
This spontaneous report as received from a healthcare worker refers to an unknown number of patients of unknown ages. On unknown dates, patients may have been administered RECOMBIVAX HB that was exposed to -0.6 C for 4860 minutes, or 81 hours, on "10 or 11 occasions from 10/31 to 11/13" (year unspecified) (dose route and lot number were not reported). No concomitant medications were reported. No adverse effects reported. This is one of several reports from the same source (MARRS#1311USA009163 and MARRS#1311USA008513). Additional information has been requested.
Diarrhea, upset stomach, vomiting, headache, tired and weak.  Tylenol and white soda
Moderate but sometimes severe joint pain in both of the knees; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 26Mar2021 at 12:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW6511) via an unspecified route of administration in the left arm on 05Mar2021 at 12:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. On 01Apr2021 at 12:00, the patient experienced moderate but sometimes severe joint pain in both the knees. The event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event moderate but sometimes severe joint pain in both the knees was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Initial unsolicited report received from non-health professional (consumer) on 30-October-2015. This case involves a 49 year old female patient who was vaccinated with a dose of FLUZONE QIV (batch number: UI441AB, expiration date, dose, dose number, and site of administration not reported) given intramuscularly on 20-October-2015. The patient's medical history was reported as none. The patient denies of any vaccine as concomitant medication taken within 4 weeks of vaccination. On 30-october-2015, ten days following the vaccination, the patient developed red, raised, firm area at injection site that was warm to touch and also painful from neck to fingertips. Laboratory investigations were not reported. Corrective treatment was not reported. Outcome of the events was unknown. List of documents held by sender: none.
Got the shot, still got it/suspected vaccination failure; Have it on left side of face, still got it; pain is indescribable.; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, more than 2 years after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure and pain were unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.     Additional Information: GSK receipt date: 16-Oct-2022 Reporter's comment: The case was received form the patient via interactive digital media. The patient stated that he/she had heard. The patient got the shot back in 2018 but still got them. The patient had them on the left side of his/her face going on his/her 4th week also. The pain was indescribable. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available. As it was reported that the patient was in 4th week and shingles on left side face going on therefore time to onset was captured as more than 2 years and outcome was not recovered.
Pt completed the COVID-19 Pfizer immunization series on 8/24/21. Pt was admitted to reporting hospital on 8/30 and discharged on 8/31/21. Patient had been having symptoms for 5 days prior to seeking help. Her primary complaint was fatigue, cough, urinary frequency, loose stools and headache. Symptomatic COVID-19 screening was positive 8/30/21 via PCR NP swab.
Redness, tenderness warm to touch local reaction the next day.  Fever  (100.3) , HA, body aches the next evening